Ying Hu

机构：Stomatology Hospital, Beijing Shijitan Hospital, Shanghai Cell Therapy Research Institute · ORCID：0000-0003-0301-7273

发表论文 139 篇 · 总被引 2480 次 · h-index 28

代表论文

• Upregulation of miR-3130-5p Enhances Hepatocellular Carcinoma Growth by Suppressing Ferredoxin 1 : miR-3130-5p Enhances HCC Growth via Inhibiting FDX1 (2025 · Current Molecular Pharmacology · 被引 41)
• Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With EGFR Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Cancers (2025 · Cancer Medicine · 被引 6)
• Green Synthesis of Dracocephalum kotschyi-Coated Silver Nanoparticles: Antimicrobial, Antioxidant, and Anticancer Potentials (2024 · Medical Science Monitor · 被引 5)
• Plasma metabolomics combined with mass spectrometry imaging reveals crosstalk between tumor and plasma in gastric cancer genesis and metastasis (2024 · Chinese Chemical Letters · 被引 5)
• Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation (2025 · Cell Reports Medicine · 被引 4)
• CDKN2A somatic copy number amplification in normal tissues surrounding gastric carcinoma reduces cancer metastasis risk in droplet digital PCR analysis (2024 · Gastric Cancer · 被引 4)